BACR Annual Meeting 2024
Recent Advances in Radioimmunotherapy
Program Registration Abstract Venue Sponsors
THE ONLINE ABSTRACT BOOK WILL BE AVAILABLE HERE.
Scientific committee: BACR Board
| 9:00 | Registration, poster mounting & coffee |
| 9:30 – 12:15 | MORNING SESSION Chair: Prof. Dirk Van Gestel |
| 9:30 | Introduction (Akeila Bellahcène & Dirk Van Gestel) |
| 9:45 |
Philippe Lambin, Maastricht University, Maastricht, The Netherlands
Radiotherapy meets immunotherapy: which immunotherapy? Which radiotherapy?
|
| 10:15 |
Eric Deutsch, Gustave Roussy, Paris, France
From low doses to the tumor intestinal irradiation doses for personalized immunoradiotherapy
|
| 10:45 | Coffee break & Poster viewing |
| 11:15 | Young investigators: oral presentations of 4 selected abstracts Philippine Bruno, Université Catholique de Louvain
Spatial and circadian regulations of cancer cell (lipid) metabolism: new insights for a better use of metabolism-targeting drugs
Barbara Stepic, University of Ghent
RIPK4 as a safeguard of epidermal homeostasis and tumorigenesis
Cyril Bodart, Université Libre de Bruxelles
SHIP2 regulates cell growth in Esophageal Squamous Cell Carcinoma in vivo
Morgane Pacque, University of Liège
mTORC2-dependent reprogramming of lipid metabolism is a metabolic vulnerability in lung cancer
|
| 12:15 | BACR: general assembly (members only) |
| 12:30 – 14:00 | LUNCH AND POSTER SESSION |
| 14:00 – 16:45 | AFTERNOON SESSION Chair: Prof. Akeila Bellahcène |
| 14:00 | Young investigators: oral presentations of 4 selected abstracts
Ioanna Petta, University of Ghent
Immune and microbiota cross-talk in colorectal cancer immune therapy efficacy
Morgane Cogels, Université Libre de Bruxelles
Investigating the immunomodulatory effects of radio-immunotherapy combination in a humanized mouse model
Ruyveda Dok, Katholieke Universiteit Leuven
Influence of hypoxia on the radiotherapy response in HPV+ and HPV- head and neck cancer
Laura Gerardelli, University of Liège
Targeting the CCL5-CCR5 axis to tackle chemoresistant malignant pleural mesothelioma
|
| 15:00 | Coffee break |
| 15:30 |
Karen Willard-Callo, Institut Jules Bordet – HUB, Brussels, Belgium
The how and why tumor-associated tertiary lymphoid structures play a key role in human cancer treatment responses
|
| 16:00 |
Alex De Caluwé, Institut Jules Bordet, Brussels, Belgium
Radioimmunotherapy in breast cancer
|
| 16:30 | Awards ceremony for best oral and poster presentations Concluding remarks |
| 16:45 | End of conference |